In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Residual Tumor Identification with Intra-operative Contrast-enhanced Ultrasound During Glioblastoma Resection

    Final Number:
    1601

    Authors:
    Francesco Prada MD; Massimiliano Del Bene; Riccardo Fornaro; Ignazio G. Vetrano MD; Alberto Martegani; Luca Aiani; Luca Maria Sconfienza; Giovanni Mauri; Luigi Solbiati; Bianca Pollo MD; Francesco DiMeco MD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2017 Annual Meeting

    Introduction: Our purpose was to assess contrast-enhanced ultrasound (CEUS) capability to identify residual tumor mass during glioblastoma (GBM) surgery, in order to increase the extent of resection.

    Methods: We prospectively evaluated 10 patients who underwent surgery for GBM removal with navigated ultrasound guidance. Navigated B-mode and CEUS were performed prior to resection, during resection and after complete tumor resection. Areas suspected for residual tumors on B-mode and CEUS were localized within the surgical field with navigated ultrasound and sent separately for histopathological analysis to confirm tumor presence.

    Results: In all cases tumor remnants were visualized as hyperechoic areas on B-mode, highlighted as CEUS positive areas and confirmed as tumoral areas on hystopathological analysis. In 1 case only CEUS partially failed to demonstrate residual tumor because the residual hyperehoic area was devascularized prior to ultrasound contrast agent injection. In all cases CEUS enhanced B-mode findings.

    Conclusions: As already shown in other neoplastic lesions in other organs CEUS is extremely specific in the identification of residual tumor. CEUS distinction between tumor and artifacts/normal brain on B-mode is based on its capability to show the vascularization degree and not the echogenicity of the tissues. Therefore, CEUS can play a decisive role in the process of maximizing GBM surgical resection.

    Patient Care: UCA can play a decisive role in the process of maximizing surgical resection as they precisely identify and locate neoplastic tissue, both prior and after resection, allowing for safe removal.

    Learning Objectives: To understand CEUS role in identifying residual tumor mass in GBMs’ surgery, thus enhancing tumor resection

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy